Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 7—July 2008

CME ACTIVITY - Research

Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office

Moon J. Kim*Comments to Author , Elizabeth Bancroft*, Eleanor Lehnkering*, Rodney M. Donlan†, and Laurene Mascola*
Author affiliations: *Los Angeles County Department of Public Health, Los Angeles, California, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Figure 2

Pulsed-field gel electrophoresis of isolates from patients with Alcaligenes xylosoxidans bloodstream infection. Lane 1, laboratory standard; lanes 2 and 6, community strains of A. xylosoxidans; lanes 3–5 and 7–13, outbreak strains; lane 14, central venous catheter (CVC) port biofilm outbreak strain; lane 15, CVC port outbreak stain.

Figure 2. Pulsed-field gel electrophoresis of isolates from patients with Alcaligenes xylosoxidans bloodstream infection. Lane 1, laboratory standard; lanes 2 and 6, community strains of A. xylosoxidans; lanes 3–5 and 7–13, outbreak strains; lane 14, central venous catheter (CVC) port biofilm outbreak strain; lane 15, CVC port outbreak stain.

Main Article

TOP